Cancer Clinical Investigation

Search results

• Dr. Galsky on Updated Findings From the CheckMate-274 Trial in Urothelial Cancer

  Matthew Galsky

  17/02/23

  1 item of Media coverage

  Press/Media

• Recent Studies from Massachusetts General Hospital Add New Data to Neoplasms (PD-1 inhibition in advanced myeloproliferative neoplasms)

  Nina Bhardwaj

  17/02/23

  1 item of Media coverage

  Press/Media

• Immunotherapy after surgery provides significant, durable benefit for high-risk bladder patients

  Matthew Galsky

  16/02/23 → 17/02/23

  2 items of Media coverage

  Press/Media

• Experimental cancer therapy shows success in more than 70% of patients in global clinical trials;

  Ajai Chari

  16/02/23

  1 item of Media coverage

  Press/Media

• Recent Findings in Influenza A Virus Described by a Researcher from Yangzhou University (Inhibition of EZH2 Causes Retrotransposon Derepression and Immune Activation in Porcine Lung Alveolar Macrophages)

  Jian Jin

  14/02/23

  1 item of Media coverage

  Press/Media

• US Patent Issued to Icahn School of Medicine at Mount Sinai on Feb. 14 for "Method of predicting graft versus host disease" (New York Inventors)

  John Levine, James Ferrara & Umut Özbek

  14/02/23

  1 item of Media coverage

  Press/Media

• Fallopian tube removal to help prevent ovarian cancer? Why experts suggest it

  Stephanie Blank

  9/02/23

  1 item of Media coverage

  Press/Media

• Renewed calls for fallopian tube removal to avoid ovarian cancer

  Stephanie Blank

  8/02/23

  2 items of Media coverage

  Press/Media

• Fallopian tube removal to help prevent ovarian cancer? Why experts are suggesting it

  Stephanie Blank

  8/02/23

  1 item of Media coverage

  Press/Media

• Removing fallopian tubes may reduce risk of Ovarian Cancer, experts say

  Stephanie Blank

  8/02/23

  4 items of Media coverage

  Press/Media

• Fallopian tube removal to help prevent ovarian cancer? Why experts are suggesting it

  Stephanie Blank

  8/02/23

  7 items of Media coverage

  Press/Media

• AML Research From ASH 2022: Novel Combinations and Evidence That “Less is More”

  John Mascarenhas

  8/02/23

  1 item of Media coverage

  Press/Media

• Dr. Mascarenhas on the Evolution of JAK Inhibitors in Myelofibrosis

  John Mascarenhas

  7/02/23

  1 item of Media coverage

  Press/Media

• Research on Life Sciences Detailed by a Researcher at Vrije Universiteit Amsterdam (The energetic effect of hip flexion and retraction in walking at different speeds: a modeling study)

  Jian Jin

  6/02/23

  1 item of Media coverage

  Press/Media

• Monday, February 6, 2023

  Linda Prine & Nina Bhardwaj

  6/02/23

  1 item of Media coverage

  Press/Media

• More Women Should Get Fallopian Tubes Removed to Prevent Cancer, Experts Advise

  Stephanie Blank

  6/02/23

  1 item of Media coverage

  Press/Media

• Cancer Vaccines Are Already A Reality—But Your Doctor Can’t Tell You About Them Unless You Ask

  Nina Bhardwaj

  5/02/23

  1 item of Media coverage

  Press/Media

• Cancer vaccines are already a reality—but your doctor might not tell you about them unless you ask

  Nina Bhardwaj

  4/02/23

  1 item of Media coverage

  Press/Media

• Breast Cancer Expert Focuses on Decoding Biomarkers

  Joseph Sparano

  2/02/23

  1 item of Media coverage

  Press/Media

• Woman, 36, details rare cervical cancer diagnosis while pregnant with 1st child

  Marshall Posner

  1/02/23

  2 items of Media coverage

  Press/Media

• Difficulty fitting family into career: Female oncologists

  Stephanie Blank

  31/01/23

  2 items of Media coverage

  Press/Media

• Cell BioEngines Enters into Licensing Agreement with Icahn School of Medicine at Mount Sinai

  Nina Bhardwaj

  27/01/23

  1 item of Media coverage

  Press/Media

• Dr. Goodman on the Use of SBRT in Locally Advanced Pancreatic Cancer

  Karyn Goodman

  27/01/23

  1 item of Media coverage

  Press/Media

• Cell BioEngines Enters into an Exclusive Worldwide Agreement to Develop and Commercialize Potent Immune Cell States to Cure Cancer

  Nina Bhardwaj

  25/01/23 → 26/01/23

  92 items of Media coverage

  Press/Media

• Cell BioEngines Enters into an Exclusive Worldwide Agreement to Develop and Commercialize Potent Immune Cell States to Cure Cancer

  Nina Bhardwaj

  26/01/23

  1 item of Media coverage

  Press/Media